Health condition
Childhood-onset schizophrenia, early recognition, coordinated care and steady family support.
Rare, serious and often frightening for families - and treatable in a specialist CAMHS and Early Intervention in Psychosis team. Here is what to expect from a modern UK pathway.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against NICE CG155, the Royal College of Psychiatrists and peer-reviewed sources you can see at the end.
- 03
Current for 2026
Reflects modern UK CAMHS and Early Intervention in Psychosis practice, including second-generation antipsychotic and clozapine monitoring.
Key facts
Childhood schizophrenia at a glance.
The essentials, in plain English - what it is, how rare it is, and how a modern UK team approaches care.
-
What it is
A severe psychotic illness starting before adulthood. Childhood-onset schizophrenia (COS) begins before age 13. Early-onset (EOS) begins before age 18.
-
How rare
COS is very rare, affecting fewer than 1 in 10,000 children. EOS is more common in adolescence but still uncommon.
-
Genetics
A strong genetic loading is typical. Copy-number variants such as the 22q11.2 deletion are found more often than in adult-onset disease.
-
Core features
A mix of positive symptoms (hallucinations, delusions, disorganised thinking), negative symptoms and cognitive impairment.
-
Foundation of care
A specialist Early Intervention in Psychosis (EIP) service alongside CAMHS, with second-generation antipsychotics and family-based therapy.
-
Prognosis
Often progressive with a poorer outcome than adult-onset schizophrenia. Early, coordinated care improves function and reduces relapse.
Why this guide matters
A coordinated pathway, not a single prescription.
Childhood-onset psychosis is complex, but the shape of good care is well understood. Three points anchor the rest of this page.
-
Early Intervention in Psychosis matters
An EIP team alongside CAMHS shortens the duration of untreated psychosis and improves long-term function and relapse rates.
-
Rule out medical mimics first
Autoimmune encephalitis, temporal lobe epilepsy, Wilson disease and drug-induced psychosis can all look like schizophrenia and need urgent, different treatment.
-
Family and school are part of the treatment
Family intervention, educational support and a safe home environment change outcomes as much as medication.
How the diagnosis is made
From first worries to a clear plan.
The steps a UK CAMHS team, EIP service and paediatric neurology will normally follow, in order - so families know what to expect and why.
Phase 1 · Assessing
History, mental state and differential
Phase 2 · Confirming
Physical, bloods, imaging and EEG
Phase 3 · Planning
Genetics and MDT formulation
- 01
Assessing
Developmental and collateral history
A careful account from parents, carers and school of prodromal changes: social withdrawal, academic decline, odd behaviour, sleep and mood changes.
- 02
Assessing
Mental state and structured tools
A full MSE with structured aids such as K-SADS, PANSS and WISC to map symptoms, function and cognition.
- 03
Assessing
Rule out other causes
Consider autism spectrum, intellectual disability, trauma and PTSD, drug-induced psychosis, mood disorder with psychosis and culturally normal experiences.
- 04
Confirming
Physical and neurological screen
Full examination looking for signs of encephalitis, seizure activity, movement disorder, Wilson disease or systemic illness.
- 05
Confirming
Bloods, imaging and EEG
FBC, U and Es, LFTs, TSH, ceruloplasmin and copper, autoimmune screen (ANA, ANCA, anti-NMDAR, LGI1, CASPR2), syphilis and HIV, drugs of abuse, heavy metals, MRI brain and EEG.
- 06
Planning
Genetic and specialist tests
Chromosomal microarray, 22q11 deletion testing and, where indicated, whole exome sequencing. Lumbar puncture if autoimmune encephalitis is suspected.
- 07
Planning
MDT formulation and plan
Child and adolescent psychiatry, paediatric neurology, clinical genetics and EIP agree a formulation, safety plan and treatment ladder.
Typical timeline: initial CAMHS or EIP assessment within weeks, with a full MDT formulation shortly after.
Symptoms
What childhood-onset psychosis can look like.
A mix of positive, negative and cognitive features, usually preceded by weeks or months of quieter prodromal changes at home and school.
-
Auditory hallucinations
Hearing voices commenting, arguing or commanding. Often the earliest and most distressing positive symptom in COS.
-
Visual hallucinations
More common in children than in adult-onset disease. Always warrants a careful search for a medical or neurological cause.
-
Delusions
Fixed, false beliefs, often persecutory or bizarre, that are out of keeping with the child’s developmental level and culture.
-
Disorganised speech and behaviour
Loose associations, tangential thinking, incoherence or catatonic features that disrupt school, self-care and relationships.
-
Negative symptoms
Avolition, alogia, flattened affect, social withdrawal and anhedonia. These often drive long-term disability more than positive symptoms.
-
Cognitive impairment
Slowed processing, poor working memory and attention. Frequently pre-dates the first psychotic episode.
-
Prodromal changes
Social withdrawal, odd behaviour, academic decline, disturbed sleep, mood changes and reduced attention over weeks to months.
-
Red flag: acute onset or neurology
Sudden severe onset, seizures, movement disorder or reduced consciousness suggests encephalitis or another medical cause and needs urgent hospital review.
Treatment
How childhood-onset schizophrenia is treated in the UK.
A NICE CG155 pathway: an EIP-led team, second-generation antipsychotics, CBT for psychosis and family intervention, with clozapine reserved for treatment-resistant illness.
-
Early Intervention in Psychosis
A specialist EIP team, typically for ages 14 to 35, coordinates assessment, medication, therapy and support across health, education and social care.
-
Second-generation antipsychotic
First-line medication in NICE CG155: aripiprazole, risperidone, olanzapine or quetiapine, at adolescent-appropriate doses with careful monitoring.
-
Clozapine for treatment-resistance
Considered when two adequate antipsychotic trials have failed. Requires strict FBC monitoring, metabolic checks and specialist oversight.
-
CBT for psychosis
Structured cognitive behavioural therapy adapted for young people, targeting distressing voices, beliefs and coping strategies.
-
Family intervention
Formal family therapy and psychoeducation to reduce expressed emotion, improve communication and support the young person at home.
-
Educational and vocational support
Occupational therapy, EHCP where appropriate, school liaison and, for older adolescents, supported employment or education programmes.
-
Substance misuse treatment
Focused help with cannabis and other substances, which can precipitate and worsen psychosis in vulnerable young people.
-
CAMHS inpatient (Tier 4)
Specialist adolescent inpatient admission for severe symptoms, high risk or treatment-resistant illness, close to home wherever possible.
Wrapping around the young person
The wider team behind the plan.
Care is delivered by a multidisciplinary team of child and adolescent psychiatry, EIP, educational psychology and social care, with input from specialist COS clinics such as those at the Maudsley and Great Ormond Street when appropriate. Charities including Rethink Mental Illness, Mind and YoungMinds provide practical family support alongside NHS care. Transition to adult psychiatry is planned early so nothing falls through the gap at 18.
What this guide is based on
The sources behind every claim on this page.
UK national guidance and specialist society standards, current at the time of last review.
Key references
Guidelines and standards we relied on.
A quiet reminder
This guide is for information, not medical advice.
A CAMHS clinician or child psychiatrist knows the young person and their history and can tell you which parts apply. If you are worried about safety, do not wait: contact your CAMHS crisis line, 111 option 2 or A and E.
-
NICE. Psychosis and schizophrenia in children and young people: recognition and management (CG155).
-
NICE. Psychosis and schizophrenia in adults: prevention and management (CG178).
-
Royal College of Psychiatrists. Faculty of Child and Adolescent Psychiatry guidance on psychosis in young people.
-
British Association for Psychopharmacology. Consensus guidance on the use of antipsychotic medication in children and adolescents.
-
MHRA. Safety information on antipsychotic medicines, including clozapine monitoring.
Red flags
When childhood psychosis needs urgent help.
Most young people with psychosis can be supported through planned CAMHS and EIP care. These are the situations that need same-day help.
-
Suicidal thoughts or acts
Any active suicidal ideation, plans or self-harm needs same-day crisis assessment via CAMHS crisis, 111 option 2 or A and E.
-
Command hallucinations
Voices instructing the young person to harm themselves or others require urgent psychiatric review and a written safety plan.
-
Acute confusion or reduced consciousness
Sudden change in level of consciousness, disorientation or fluctuating alertness suggests delirium or encephalitis and needs A and E.
-
New seizures or movement disorder
First seizure, dystonia or abnormal movements alongside psychosis point to a neurological or autoimmune cause and need urgent investigation.
-
Suspected anti-NMDAR encephalitis
Rapid personality change, seizures, movement disorder and autonomic instability in a previously well child needs immediate neurology input and CSF testing.
-
Neuroleptic malignant syndrome
Fever, rigidity, autonomic instability and confusion on an antipsychotic is a medical emergency. Stop the drug and call 999.
-
Severe self-neglect or catatonia
Refusing food or fluids, mutism or stupor needs urgent inpatient CAMHS review, often with medical monitoring.
-
Escalating cannabis or stimulant use
Ongoing cannabis, methamphetamine or hallucinogen use in a young person with psychosis significantly worsens outcomes and needs specialist help.
-
Rapid weight or metabolic change
Rapid weight gain, new diabetes or lipid changes on an antipsychotic need review of the drug choice and metabolic support.
Living with it
A serious illness, with a shared plan.
Four things that make the biggest difference day to day - one team around the young person, steady routines, no cannabis and a written safety plan.
A quiet reminder
Small, steady support outperforms crisis heroics.
Predictable routines and calm, warm homes are among the strongest protective factors we know of. Ordinary consistency is treatment.
- 01 Team
Keep one team around the young person
CAMHS, EIP, school and family working from one plan makes a bigger difference than any single treatment on its own.
- 02 Routine
Sleep, structure and low stress
Regular sleep, predictable days and reduced conflict at home protect against relapse and support recovery.
- 03 Substances
Say no to cannabis
Cannabis is a well-recognised trigger for relapse in young people with psychosis. Stopping is one of the most powerful things a family can support.
- 04 Plan
A written safety and crisis plan
Every young person should have a clear plan naming who to call, when, and what to try first when symptoms return.
Frequently asked
Everything we get asked about childhood schizophrenia.
Quick answers on early recognition, differential diagnosis, medication and family support.
-
What is childhood-onset schizophrenia?
Childhood-onset schizophrenia (COS) is a severe psychotic illness that begins before the age of 13. Early-onset schizophrenia (EOS) begins before the age of 18. Both feature hallucinations, delusions, disorganised thinking, negative symptoms and cognitive difficulties, and both are far rarer than adult-onset schizophrenia.
-
How is it different from autism or trauma?
Autism is a lifelong neurodevelopmental condition present from early childhood, without true hallucinations or delusions. Trauma and PTSD can produce flashbacks and dissociation that look psychotic but usually have a clear traumatic trigger. A specialist assessment, developmental history and, where needed, structured tools such as K-SADS help tell them apart.
-
Can drugs cause similar symptoms?
Yes. Cannabis, methamphetamine and hallucinogens can trigger psychotic symptoms, especially in young people with a genetic vulnerability. A urine drug screen is a routine part of assessment, and stopping cannabis is a key part of treatment and relapse prevention.
-
What medicines are used?
NICE CG155 recommends a second-generation antipsychotic such as aripiprazole, risperidone, olanzapine or quetiapine as first-line treatment, at adolescent-appropriate doses. Clozapine is considered for treatment-resistant illness after two adequate antipsychotic trials, with strict blood and metabolic monitoring.
-
What else helps besides medicine?
CBT for psychosis, family intervention, psychoeducation, occupational therapy, educational support with an EHCP where appropriate, and help with any substance misuse. Care is coordinated by CAMHS with an Early Intervention in Psychosis service, and specialist COS clinics such as those at the Maudsley and Great Ormond Street can offer additional expertise.
-
What is the outlook?
Childhood-onset schizophrenia tends to have a more difficult course than adult-onset disease, with more persistent symptoms and greater functional impact. Early diagnosis, coordinated MDT care, family support, avoidance of cannabis and a planned transition to adult psychiatry give the best chance of a fuller life.
Related content
Keep reading.
-
Autism spectrum disorder
A key differential in young people with unusual behaviour.
Learn more -
ADHD
Often coexists and needs careful assessment.
Learn more -
Autoimmune encephalitis
A medical mimic that must be excluded urgently.
Learn more -
Complicated grief
Related mental health condition in young people.
Learn more -
Cyclothymia
Mood disorder that can complicate the picture.
Learn more -
Mental health crisis assessment
When to seek urgent psychiatric help.
Learn more -
Adult autism assessment clinic
Specialist neurodevelopmental assessment.
Learn more -
Mental health consultation
A first psychiatric consultation.
Learn more -
Whole exome sequencing
Genetic test used in complex neuropsychiatric presentations.
Learn more -
All conditions
Browse every clinical guide.
Learn more